Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Non-Current Deferred Tax Liability (2016 - 2025)

Fresenius Medical Care AG (FMS) has 16 years of Non-Current Deferred Tax Liability data on record, last reported at $802.6 million in Q4 2025.

  • For Q4 2025, Non-Current Deferred Tax Liability rose 5.96% year-over-year to $802.6 million; the TTM value through Dec 2025 reached $802.6 million, up 5.96%, while the annual FY2025 figure was $779.0 million, 1.53% up from the prior year.
  • Non-Current Deferred Tax Liability reached $802.6 million in Q4 2025 per FMS's latest filing, up from $757.5 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $993.5 million in Q4 2021 and bottomed at $757.5 million in Q4 2024.
  • Average Non-Current Deferred Tax Liability over 4 years is $877.3 million, with a median of $879.0 million recorded in 2025.
  • Peak YoY movement for Non-Current Deferred Tax Liability: grew 6.03% in 2021, then fell 3.83% in 2022.
  • A 4-year view of Non-Current Deferred Tax Liability shows it stood at $993.5 million in 2021, then dropped by 3.83% to $955.4 million in 2022, then dropped by 20.72% to $757.5 million in 2024, then increased by 5.96% to $802.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Deferred Tax Liability were $802.6 million in Q4 2025, $757.5 million in Q4 2024, and $955.4 million in Q4 2022.